Health Care & Insurance April 18, 2018 9:16:19 pm

Boulder’s bioscience industry growing to critical mass

Participants of BizWest’s CEO Roundtable on Life Sciences in Boulder are, from left, Misha Plam, Ron Squarer, David Kerr, William Marshall, Chris Shapard, Jennifer Jones, Tin Tin Su, Pawel Fludzinski, Amy Beckley, Tom Cech, Becky Potts, Kyle Lefkoff, Tom Hertzberg, Jonathan Vaught, Marvin Caruthers, Not pictured: Brynmor Reese. BizWest/Jensen Werley.

By Jensen Werley

BOULDER — After years of companies being sold off or growing and relocating, Boulder’s life-sciences sector is showing signs of reaching critical mass.

Companies such as Clovis Oncology Inc. (Nasdaq: CLVS), SomaLogic Inc., Array Biopharma Inc. (Nasdaq: ARRY) and miRagen Therapeutics Inc. (Nasdaq: MGEN) are showing that homegrown businesses can continue to foster momentum and prove to venture capitalists and legacy companies on the East and West coasts that Boulder is a place for biotech, according to those attending BizWest’s CEO Roundtable on Life Sciences at the Jennie Smoly Caruthers Bioscience Building on the University of Colorado Boulder…

THIS ARTICLE IS FOR SUBSCRIBERS ONLY

Continue reading for less than $3 per week!

Get a month of award-winning local business news, trends and insights

Access award-winning content today!

Subscribe Now

Already have a paid subscription?